Industry Day- 2019 :: Interview with Dr Jitendar Sharma

Dr Jitendar Sharma is the Managing Director & CEO of Andhra Pradesh MedTechZone(AMTZ) and Executive Director of Kalam Institute of Health Technology (KIHT)-a technology policy research body setup with the support of Government of India and Executive Chairman of BioValley & MediValley–two med-tech incubators. He is an Adjunct faculty at University of Adelaid, ,Australia and program Director for Health Technology Assessment (HTA)fellowships in India.

Dr.Sharma has authored seven books and has been a key designer and coordinator for several health programs in India.

As a Speaker for the upcoming Industry Day on September 21, he talks about industry-academia collaboration, challenges in academia collaboration in the field of sustainable medical technologies and more.

Edited Excerpts of an interview with Dr Vanita Srivastava

How do you see events like the industry day forge better academia-industry relationship?

 

Academia and industry are two important pillars of our economy. A robust collaboration between the two will augur well for our developing economy, enabling innovation, growth in the education system and producing an employment-ready workforce.

Those entering the job market today are ready to learn new technologies and how to collaborate. Entrepreneurs and educational institutes need to recognise this opportunity and build a constructive framework for collaboration to make India a global innovation hub.

AMTZ encourages events like Industry Day as this platform enables convergence of various innovations. The industry should seek help from academia for innovations as they have a broader scope for experimentation.

The country is currently at a juncture where platforms like AMTZ –Kalam Institute of Health Technology are playing a major role in the transformational story.

 

Please give a brief on what you will be talking

 

I will be talking on the subject-Quantifying Innovation through industry and university collaboration.

 

In the field of sustainable medical technologies, what are the major challenges in collaboration with the academia. How can these challenges be addressed?

 

Some of the challenges include—a weak market orientation and lack of clarity on how to commercialize. There should me more academia-industry orientation which will lead to more alignment of the two. More joint projects should be undertaken. Emphasis should be on inculcating a sense of commercialization.

 

How do you see the academia helping the industry in technological intervention and vice versa.

 

Many Healthtech companies are partnering with engineering colleges and universities. At AMTZ we work closely with academia in aligning their innovations to industry and help them commercialize it. We also train academia and students to align with industry needs by giving them exposure to world class labs and manufacturing zone.

We have successfully developed 3D printed ear implants, dialyzers, capsule endoscopy through academia and industry collaboration. This collaboration has also lead to developing bio harmonized Aids for Rehabilitation and treatment (BHARAT) project – 3D printed heart.